Skip Navigation
Skip to contents

PHRP : Osong Public Health and Research Perspectives

OPEN ACCESS
SEARCH
Search

Search

Page Path
HOME > Search
1 "financial structure"
Filter
Filter
Article category
Keywords
Publication year
Authors
Original Article
The Determinants of Research and Development Investment in the Pharmaceutical Industry: Focus on Financial Structures
Munjae Lee, Mankyu Choi
Osong Public Health Res Perspect. 2015;6(5):302-309.   Published online October 31, 2015
DOI: https://doi.org/10.1016/j.phrp.2015.10.013
  • 2,834 View
  • 16 Download
  • 22 Crossref
AbstractAbstract PDF
Objectives
This study analyzes the influence of the financial structure of pharmaceutical companies on R&D investment to create a next-generation profit source or develop relatively cost-effective drugs to maximize enterprise value.
Methods
The period of the empirical analysis is from 2000 to 2012. Financial statements and comments in general and internal transactions were extracted from TS-2000 of the Korea Listed Company Association (KLCA), and data related to stock price is extracted from KISVALUE-Ⅲ of NICE Information Service Co., Ltd. Stata 12.0 was used as the statistical package for panel analysis.
Results
The current ratio had a positive influence on R&D investment, the debt ratio had a negative influence on R&D investment, and return on investment and net sales growth rate did not have a significant influence on R&D investment.
Conclusion
It was found in this study that the higher liquidity ratio, the greater the R&D investment. The stability of pharmaceutical companies has a negative influence on R&D investment. This finding is consistent with the prediction that if a company faces a financial risk, it will be passive in R&D investment due to its financial difficulties.

Citations

Citations to this article as recorded by  
  • How Indian Pharma Industry Performed in the Last Decade? Impact of a Non-macroeconomic Variable and Financial Distress
    Pooja Singh, Anindita Chakraborty
    Jindal Journal of Business Research.2023; 12(2): 143.     CrossRef
  • How structural changes are driving R&D activity in India’s pharmaceutical sector
    Niloufer Sohrabji, Kristen Marquette
    Journal of Pharmaceutical Health Services Research.2023; 14(3): 256.     CrossRef
  • Patent and Marketing Exclusivities 101 for Drug Developers
    Bryan Oronsky, Scott Caroen, Franck Brinkhaus, Tony Reid, Meaghan Stirn, Raj Kumar
    Recent Patents on Biotechnology.2023; 17(3): 257.     CrossRef
  • The driving process of technological innovation in construction: a firm-level CDM analysis
    Zheng Gong, Nannan Wang
    Construction Innovation .2022; 22(2): 222.     CrossRef
  • Envisioning the challenges of the pharmaceutical sector in the Indian health-care industry: a scenario analysis
    Giuseppe Festa, Ashutosh Kolte, Maria Rosaria Carli, Matteo Rossi
    Journal of Business & Industrial Marketing.2022; 37(8): 1662.     CrossRef
  • Can the Profitability of Medical Enterprises Be Improved After Joining China's Centralized Drug Procurement? A Difference-in-Difference Design
    Yu-Fei Hua, Jin Lu, Bing Bai, Han-Qing Zhao
    Frontiers in Public Health.2022;[Epub]     CrossRef
  • Ambidexterity's influence on export strategy development—The case of the Indian pharmaceutical industry
    Ashutosh Kolte, Giuseppe Festa, Matteo Rossi, Alkis Thrassou, Demetris Vrontis, Michael Christofi
    Thunderbird International Business Review.2022; 64(5): 465.     CrossRef
  • Local pharmaceutical research and development capacity in a developing country: a qualitative exploration of perspectives from key stakeholders in Ethiopia
    Muluken Nigatu Selam, Samuel Abera, Helen Geremew, Eskinder Eshetu Ali
    Journal of Pharmaceutical Policy and Practice.2022;[Epub]     CrossRef
  • Optimization and Quest of HPMC loaded Stavudine Controlled Release Dosage Development by Central Composite Design utilizing Reduced Factorial Screening Technique
    Jyothsna Gangolu, Sandyapakula Balaiah, Sisir Nandi, Harekrishna Roy
    Brazilian Journal of Pharmaceutical Sciences.2022;[Epub]     CrossRef
  • The contribution of intellectual capital to financial stability in Indian pharmaceutical companies
    Giuseppe Festa, Matteo Rossi, Ashutosh Kolte, Luca Marinelli
    Journal of Intellectual Capital.2021; 22(2): 337.     CrossRef
  • Factors affecting profitability of pharmaceutical company: an Indonesian evidence
    Harianto Lim, Rofikoh Rokhim
    Journal of Economic Studies.2021; 48(5): 981.     CrossRef
  • Impact of Monetary Policy Uncertainty on R&D Investment Smoothing Behavior of Pharmaceutical Manufacturing Enterprises: Empirical Research Based on a Threshold Regression Model
    Jingyuan Yang, Ling Wang, Ziyuan Sun, Fangming Zhu, Yihui Guo, Yan Shen
    International Journal of Environmental Research an.2021; 18(21): 11560.     CrossRef
  • Drivers of ICT investments in bakery and sugar confectionery processed food sub-sector in India
    Navyashree GR, Savita Bhat
    Journal of Agribusiness in Developing and Emerging.2020; 10(2): 191.     CrossRef
  • Gouvernance et intensité d’innovation dans les ETI innovantes
    Léopold Djoutsa Wamba, Éric Braune, Frédéric Teulon
    Management & Avenir.2020; N° 118(4): 111.     CrossRef
  • MALİYET YAPIŞKANLIĞININ YENİDEN GÖZDEN GEÇİRİLMESİ: BORSA İSTANBUL İMALAT SANAYİ ÖRNEĞİ
    Mehmet Emin KARABAYIR
    Muhasebe ve Vergi Uygulamaları Dergisi.2019; 12(2): 317.     CrossRef
  • Bioaugmentation effect of Aeromonas hydrophila and Pseudomonas putida on kinetics of activated sludge process in treating pharmaceutical industrial wastewater
    Marija Vuković Domanovac, Monika Šabić Runjavec, Ernest Meštrović
    Journal of Chemical Technology & Biotechnology.2019; 94(8): 2721.     CrossRef
  • Replicating the R&D investments and financial structure relationship: evidence from Borsa İstanbul
    Nasif Ozkan
    Management Review Quarterly.2018; 68(4): 399.     CrossRef
  • Firm level R&D intensity: evidence from Indian drugs and pharmaceutical industry
    Shilpi Tyagi, D. K. Nauriyal, Rachita Gulati
    Review of Managerial Science.2018; 12(1): 167.     CrossRef
  • Impact of investment in intangible assets on corporate performance in India
    Aparna Bhatia, Khushboo Aggarwal
    International Journal of Law and Management.2018; 60(5): 1058.     CrossRef
  • Relation of R&D expense to turnover and number of listed companies in all industrial fields
    Jun-Hwan Park, Bangrae Lee, Yeong-Ho Moon, GyuSeok Kim, Lee-Nam Kwon
    Journal of Open Innovation: Technology, Market, an.2018; 4(1): 1.     CrossRef
  • Policy to encourage the development of antimicrobials
    Ayman Chit, Paul Grootendorst
    International Journal of Health Governance.2018; 23(2): 101.     CrossRef
  • O IMPACTO DOS INVESTIMENTOS EM P&D NO DESEMPENHO DAS EMPRESAS: APLICAÇÕES NO USO DE REGRESSÃO QUANTÍLICA COM VARIÁVEIS INSTRUMENTAIS
    Leonardo Andrade Rocha, Ahmad Saeed Khan, Patrícia Verônica Pinheiro Sales Lima, Maria Ester Soares Dal Poz, Carlos Alano Soares de Almeida
    Revista de Economia Contemporânea.2018;[Epub]     CrossRef

PHRP : Osong Public Health and Research Perspectives